Society for Neuroscience - Search

Skip Navigation

  • join logo Join
  • hands shaped like a yellow heart icon Give
  • advocate logo Advocate
  • publish logo Publish
  • Icon with thought bubbles Learn
Shop Sign In
SfN Logo 2025
  • Membership
    • Learn About Membership
      • Individual Member Benefits
      • Institutional Program Member Benefits
      • Sustaining Associate Member Benefits
      • Get Involved at SfN
    • Become a Member
      • Sponsorship Information for New Members
      • Membership Categories & Fees
      • Membership Fees for Developing Countries
      • Renew Individual Membership
    • Member Resources
      • Automatic Renewals
      • Frequently Asked Questions
      • Individual Member Directory
      • Member Obituaries and Memorial Donations
    • Learn About Local Chapters
      • Start or Reactivate a Chapter
      • Resources for Chapters
      • Submit Annual Report
      • Chapter Directory
      • Frequently Asked Questions
  • Meetings
    • Meetings Overview
    • Neuroscience 2025
      • Presenter Resources
      • Itinerary Planner and Mobile App
      • Sessions and Events
      • Registration
      • Housing and Travel
      • Exhibits
      • Advertising and Sponsorship
      • FAQs
    • Global Events
      • SfN Virtual Events
    • Past and Future Annual Meetings
      • Neuroscience 2024
      • Neuroscience 2023
      • Search Past Annual Meeting Abstracts
      • Attendance Statistics
    • Meeting Policies and Guidelines
      • Code of Conduct at SfN Events
      • Growth and Opportunity Strategy
      • Photography & Recording Policy
      • Presenter Guidelines and Policies for SfN Events
    • Meeting Awards
      • Trainee Professional Development Award
      • International Travel Awards
      • FENS Member Awards to SfN Annual Meeting
      • IBRO Member Awards to SfN Annual Meeting
      • JNS Member Awards to SfN Annual Meeting
  • Careers
    • Careers Overview
    • Institutional Program (IP) Directory
    • NeuroJobs Career Center
      • Job Seekers
      • Employers
    • 2025 Graduate School Fair
    • Career Tools and Resources
      • Neuronline
      • Neurobiology of Disease Workshop
      • Responsible Conduct of Research Short Courses
      • Neuroscience Departments and Program Workshop
      • Global Funding Sources
    • Higher Education and Training
      • Core Competencies
      • Neuroscience Training Program Survey
    • Awards
      • Outstanding Career and Research Achievements
      • Early Career
  • Initiatives
    • Initiatives Overview
    • Awards
      • 2025 Award Recipients
      • Awards and Prizes FAQ
      • Trainee Professional Development Award
    • Neuroscience Scholars Program
    • Neuronline
      • Webinars
      • Articles
      • Videos
      • Podcasts
      • Collections
    • Resources to Stay Connected
      • SfN Zoom Backgrounds
    • Community
    • Women and Neuroscience
      • Increasing Women in Neuroscience (IWiN) Courses & Toolkit
      • Celebration of Women in Neuroscience Event
      • Awards
    • Animals in Research
      • Support for Members and Institutions
      • Tools and Resources
      • Resources for Medical Students
    • Public Education Programs
      • Resources for Educators
      • Brain Awareness Video Contest
      • Life of a Neuron Exhibit
  • Advocacy
    • Advocacy Overview
    • Advocacy Response
    • Advocacy Network
      • The NeuroAdvocate Challenge
      • Advocacy Action Center
      • Advocacy Best Practices
      • Advocacy Network News
      • Advocacy Training Seminars
    • US Advocacy Programs
      • Capitol Hill Day
      • Connect with Policymakers
      • Early Career Policy Ambassadors
      • Partner with a Local Chapter
      • Engage the Media
    • Global Advocacy Programs
      • Global Neuroscience Initiatives
      • Global Funding
      • North American Programs
    • Science Funding
      • Advocacy Videos
      • Advocacy Resources
      • US Neuroscience Initiatives
      • Funding Priorities and Processes
    • Policy Positions
      • Statements and Testimony
      • Sign-On Letters
  • Outreach
    • Outreach Overview
    • BrainFacts.org
    • Find a Neuroscientist
    • Brain Awareness Campaign
      • Webinar: The ABC's of BAW
      • How to Get Involved
    • Awards
      • Award for Education in Neuroscience
      • Next Generation Award
      • Chapter of the Year Award
      • Science Educator Award
  • Publications
    • Publications Overview
    • SfN News
    • JNeurosci
    • eNeuro
    • SfN Nexus
    • Neuroscience Quarterly
    • Annual Report
    • History of Neuroscience Autobiographical Chapters
  • About
    • About Overview
    • Mission and Strategic Plan
    • What We Do
      • Annual Report
      • Bylaws
      • Resolutions to the Bylaws
      • Environmental Commitment
      • Strategic Partners
      • History of SfN
    • SfN 50th Anniversary Celebration
    • NIH Public Health Service-Supported Funding Financial Conflict of Interest Policy
    • Volunteer
      • SfN Council
      • SfN Presidents
      • Committees
      • Elections
      • Call for Nominations
    • Professional Conduct
      • SfN Ethics Policy
      • Guidelines for Responsible Conduct Regarding Scientific Communication
      • Code of Conduct at SfN Events
      • Commitment to Scientific Integrity
      • Neuronline Digital Learning Community Guidelines
    • History of Neuroscience
      • Autobiographical Chapters
      • Autobiographical Videos of Prominent Neuroscientists
      • Classic Papers
      • Neuroscience History Resources
      • Robert Doty's Chapter on Neuroscience
    • Careers and Staff
      • Staff List
  1. Search

Filter

  • (2)
  • (1)
  • (3)
  • (6)
  • (8)
  • (1)
  • (574)
  • (3)
  • (2)
  • (8)
Filter
171 - 180 of 892 results
  • Abstract
    Cannabinoid (THC) exposure during adolescence has enduring effects on hippocampal plasticity and learning in females
    Marijuana is the most common illicit drug abused during adolescence, a critical period in brain development. Correlational studies in humans have shown adolescent cannabis use to be associated with cognitive deficits, including deficits in episodic memo...
    Oct 23, 2019
  • Abstract
    The effect of adolescent delta-9-tetrahydrocannabinol and ethanol exposure on prefrontal cortex reliant behaviors
    Cannabis is the most commonly used illicit drug with rates of use that have steadily increased over the last decade especially in the adolescent population. Chronic abuse can lead to cannabis use disorder (CUD) which has high comorbidity rates with alco...
    Oct 22, 2019
  • Abstract
    Effects of hippocampal dysregulation on the hyper-dopaminergic state induced by chronic adolescent THC exposure
    Clinical and preclinical studies have associated adolescent cannabis exposure with a higher risk to develop neuropsychiatric disorders later in life. It is widely accepted that glutamate and dopamine (DA) dysfunctions are critical to the pathophysiology...
    Oct 21, 2019
  • Abstract
    Δ9-Tetrahydrocannabinol prevents chemotherapy-induced vomiting via the activation of cannabinoid CB1 receptors.
    Numerous clinical trials have shown that Δ 9-THC and its synthetic analogs (nabilone and levonantradol) are useful antiemetics in patients receiving chemotherapy. However, the receptor mechanism(s) by which cannabinoids prevent chemotherapy-induced emesis remains unknown. Recently, we have shown that the selective CB1 receptor antagonist SR 141716A can produce emesis in the least shrew in a dose-dependent manner when administered either intraperitoneally (ED50 = 5.5 ± 1.2 mg/kg) or subcutaneously (ED50 = 20.2 ± 1, mg/kg). The latter effect was blocked by Δ9-THC. The purpose of the present study was to investigate: 1) if Δ9-THC can prevent cisplatin-induced emesis in the least shrew, and ii) whether the latter antiemetic effect can be prevented by nonemetic doses of SR 141716A. At 0 time, different groups of shrews received varying doses of Δ9-THC (0, 1, 2.5, 5 and 10 mg/kg, i.p.) and an emetic dose of cisplatin (20 mg/kg, i.p.). The frequency of emesis was recorded for the next 60 min. Administration of Δ9...
    Nov 9, 2000
  • Repeated exposure to high-THC Cannabis smoke during gestation alters sex ratio, behavior, and amygdala gene expression of Sprague Dawley rat offspring | eNeuro
    Due to the legalization of Cannabis in many jurisdictions and trend of increasing THC content in Cannabis products, an urgent need exists to understand the impact of Cannabis use during pregnancy on fetal neurodevelopment and behavior. To this end, we exposed female Sprague-Dawley rats to Cannabis smoke daily from gestational days 6 to 20 or room-air. Maternal reproductive parameters, offspring behavior, and gene expression in the offspring amygdala were assessed. Body temperature was decreased in dams following smoke exposure and more fecal boli were observed in the chambers before and after smoke exposure in dams exposed to smoke. Maternal weight gain, food intake, gestational length, litter number, and litter weight were not altered by exposure to Cannabis smoke. A significant increase in the male-to-female ratio was noted in the Cannabis -exposed litters. In adulthood, male and female Cannabis smoke-exposed offspring explored the inner zone of an open field significantly less than control offspring. Ge...
    Nov 10, 2023 Thaisa M. Sandini
  • Repeated Exposure to High-THC Cannabis Smoke during Gestation Alters Sex Ratio, Behavior, and Amygdala Gene Expression of Sprague Dawley Rat Offspring | eNeuro
    Because of the legalization of Cannabis in many jurisdictions and the trend of increasing Δ9-tetrahydrocannabinol (THC) content in Cannabis products, an urgent need exists to understand the impact of Cannabis use during pregnancy on fetal neurodevelopment and behavior. To this end, we exposed female Sprague Dawley rats to Cannabis smoke daily from gestational day 6 to 20 or room air. Maternal reproductive parameters, offspring behavior, and gene expression in the offspring amygdala were assessed. Body temperature was decreased in dams following smoke exposure and more fecal boli were observed in the chambers before and after smoke exposure in dams exposed to smoke. Maternal weight gain, food intake, gestational length, litter number, and litter weight were not altered by exposure to Cannabis smoke. A significant increase in the male-to-female ratio was noted in the Cannabis -exposed litters. In adulthood, male and female Cannabis smoke-exposed offspring explored the inner zone of an open field significantl...
    Nov 1, 2023 Thaisa M. Sandini
  • Abstract
    Δ9-tetrahydrocannabinol (THC) produces bi-phasic rewarding and aversive effects in the anterior vs. posterior nucleus accumbens shell through dissociable μ vs κ opiate receptor mechanisms and differential modulation of medium spiny neuron activity
    The phytochemical in cannabis primarily responsible for its psychoactive properties, Δ9-tetrahydrocannabinol (THC), produces seemingly contradictory effects of reward and aversion at different doses. In addition, previous studies demonstrate that cannab...
    Nov 14, 2017
  • Abstract
    Acute THC impairs voluntary locomotor activity through both CNR1 and non- CNR1 ammonia-mediated mechanisms
    Substantial evidence indicates inhibitory effects of THC on locomotor activity. The dorsolateral striatum (DLS) has been broadly studied for its role in mediating these locomotor effects. It is widely accepted that these effects occur through presynapti...
    Nov 6, 2018
  • Abstract
    Cannabidiol decreases the excitability of pyramidal neurons and increases inhibitory drive in hippocampal area CA1
    Cannabis has been used for several centuries in the treatment of several diseases. The therapeutic potential of cannabinoids has recently resurfaced. Cannabidiol (CBD), a non-psychoactive cannabinoid, has recently been shown to decrease epileptic seizur...
    Nov 5, 2018
  • Abstract
    The effect of cannabidiol on microglial function and receptor expression in an epilepsy mouse model
    Epilepsy is a chronic disorder characterized by abnormal brain cell activity leading to recurrent, unprovoked seizures. Pharmacological therapies are commonly used for the treatment of epilepsy, although nearly 30% of patients do not respond to current ...
    Nov 3, 2018
  • Previous
  • 16
  • 17
  • 18
  • 19
  • 20
  • Next

Featured

  • SfN Selects Kevin B. Marvel, PhD, as Next Executive Director
  • Read the Neuroscience Quarterly - Fall 2025
  • Renew your SfN Membership Today!
SfN Websites
  • BrainFacts.org logo
  • eNeuro logo
  • JNeurosci logo
  • Neuronline logo
Engage with SfN
  • join Join
  • give Give
  • advocate Advocate
  • publish Publish
Quick Links
  • SfN News
  • For Press
  • Global Events
  • Contact Us
  • Advertise
  • Code of Conduct
  • Jobs at SfN
  • SfN Store
  • Social Media
Follow SfN
  • BlueSky logo
  • Facebook logo
  • Instagram logo
  • LinkedIn logo

  • Threads logo
  • X Logo
  • YouTube logo
SfN logo with "SfN" in a blue box next to Society for Neuroscience in red text and the SfN tag line that reads "Advancing the understanding of the brain and nervous system"
1121 14th Street NW, Suite 1010, Washington, D.C. 20005
(202) 962-4000 | 1-888-985-9246
  • Accessibility Policy
  • Disclaimer
  • Privacy Notice
  • Contact Us

Copyright ©
Society for Neuroscience